Genotyping and phenotyping of alpha1-antitrypsin deficiency Greek patients under augmentation therapy: a multicenter study
S. Papiris (Athens, Greece), V. Apollonatou (Athens, Greece), A. Tzouvelekis (Athens, Greece), V. Tzilas (Athens, Greece), T. Karampitsakos (Athens, Greece), I. Gerogianni (Larissa, Greece), Z. Daniil (Larissa, Greece), L. Kolilekas (Athens, Greece), A. Tsaroucha (Athens, Greece), A. Papaioannou (Athens, Greece), S. Tryfon (Thessaloniki, Greece), S. Markou (Xanthi, Greece), I. Korbila (Athens , Greece), K. Vlami (Athens , Greece), A. Dimakou (Athens , Greece), I. Papanikolaou (Corfu, Greece), M. Kitrou (Patras, Greece), Z. Sardelis (Athens , Greece), E. Stagaki (Athens , Greece), G. Apollonatos (Athens , Greece), G. Verykokou (Athens , Greece), M. Kallieri (Athens , Greece), A. Prapa (Athens , Greece), Z. Tsilogianni (Athens , Greece), N. Roussakis (Athens , Greece), E. Antonogiannaki (Athens , Greece), G. Papadaki (Athens , Greece), G. Tsinti (Larissa, Greece), M. Speletas (Larissa, Greece), T. Greulich (Marburg, Germany), D. Bouros (Athens , Greece), E. Manali (Athens, Greece)
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Session: Monitoring of inflammation in remodelling
Session type: E-poster session
Number: 3324
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Papiris (Athens, Greece), V. Apollonatou (Athens, Greece), A. Tzouvelekis (Athens, Greece), V. Tzilas (Athens, Greece), T. Karampitsakos (Athens, Greece), I. Gerogianni (Larissa, Greece), Z. Daniil (Larissa, Greece), L. Kolilekas (Athens, Greece), A. Tsaroucha (Athens, Greece), A. Papaioannou (Athens, Greece), S. Tryfon (Thessaloniki, Greece), S. Markou (Xanthi, Greece), I. Korbila (Athens , Greece), K. Vlami (Athens , Greece), A. Dimakou (Athens , Greece), I. Papanikolaou (Corfu, Greece), M. Kitrou (Patras, Greece), Z. Sardelis (Athens , Greece), E. Stagaki (Athens , Greece), G. Apollonatos (Athens , Greece), G. Verykokou (Athens , Greece), M. Kallieri (Athens , Greece), A. Prapa (Athens , Greece), Z. Tsilogianni (Athens , Greece), N. Roussakis (Athens , Greece), E. Antonogiannaki (Athens , Greece), G. Papadaki (Athens , Greece), G. Tsinti (Larissa, Greece), M. Speletas (Larissa, Greece), T. Greulich (Marburg, Germany), D. Bouros (Athens , Greece), E. Manali (Athens, Greece). Genotyping and phenotyping of alpha1-antitrypsin deficiency Greek patients under augmentation therapy: a multicenter study. 3324
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Augmentation therapy for α1 -antitrypsin deficiency: a meta-analysis of randomized and non-randomized clinical studies Source: Eur Respir J 2005; 26: Suppl. 49, 288s Year: 2005
Protocol for the EARCO Registry: a pan-European observational study in patients with a1 -antitrypsin deficiency Source: ERJ Open Res, 6 (1) 00181-2019; 10.1183/23120541.00181-2019 Year: 2020
Alpha1-antitrypsin deficiency: An analysis of patient subgroups of the German registry Source: Annual Congress 2011 - COPD mechanisms Year: 2011
Baseline characteristics of patients enrolled in the EARCO prospective registry of alpha-1 antitrypsin deficiency: preliminary results. Source: Virtual Congress 2021 – Treatments for airway diseases Year: 2021
Metabolomic approach in the characterization of omalizumab responders and non-responders among children with severe asthma: a multicenter prospective study. Source: Virtual Congress 2021 – Advances in childhood asthma: biologics, biomarkers and infections Year: 2021
Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study Source: ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019 Year: 2020
Role of bronchiectasis in alpha1-antitrypsin deficiency patients: a comparative analysis Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions Year: 2019
Pilot study for detection of alpha-1 antitrypsin deficiency in a targeted Argentinean population Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005
Effectiveness of treatments for severe sepsis: a prospective multicentre observational study in Spanish ICUs Source: Annual Congress 2009 - Severe sepsis and multiple organ failure Year: 2009
Prevalence and mechanism of pulmonary hypertension in sickle cell disease: a prospective multicentre french study Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension Year: 2009
Supplementation of N-acetylcysteine as an adjuvant in treatment of newly diagnosed pulmonary tuberculosis patients: A prospective, randomized double blind, placebo controlled study Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013
Quality of life evaluation in patients with alpha1-antitripsin deficiency: A 3-year prospectic study Source: Annual Congress 2011 - What do individuals know about their disease? Educational needs, the psychological impact of chronic respiratory disease and health-related quality of life Year: 2011
Biomarker measurement in asthma patients receiving biologic therapy: a real-world retrospective study Source: International Congress 2018 – Eosinophils in airway disease Year: 2018
Home care combining oral nutritional supplement, exercise and androgen substitution in malnourished patients with chronic respiratory failure: a prospective controlled randomized multicenter trial Source: Annual Congress 2008 - Integrated care and long-term strategies Year: 2008
What makes Alpha1-antitrypsin deficiency patients exacerbate: a 5-year cohort Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021
Clinical phenotypes of extrapulmonary sarcoidosis: an analysis of a French, multi-ethnic, multicentre cohort Source: Eur Respir J, 57 (4) 2001160; 10.1183/13993003.01160-2020 Year: 2021
A new prospective multicenter study of EBV treatment of homogeneous disease: A status report Source: Annual Congress 2013 –Endoscopic lung volume reduction & newest clinical data Year: 2013
Analysis of the efficacy of moxifloxacin for the treatment of bronchial colonization in COPD patients using microbial molecular typing: a randomized, double-blind, placebo-controlled study Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008
Clinical phenotype of individuals with common COPD investigated during the targeted detection programme for alpha1-antitrypsin deficiency in Italy Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007
Clinical, functional, radiologic and quality of life characteristics in PI*SZ Alpha 1-Antitrypsin Deficiency (AATD) compared to PI*ZZ, PI*MZ and COPD without AATD: a retrospective cohort study. Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021